Case Report


How acute viral keratoconjunctivitis change the ocular tear film

Ni Made Indah Kencanawati1
,  
Stephanie Aurelia Santoso2

1 Ophthalmologist, Department of Ophthalmology, Bali Mandara Eye Hospital, Denpasar, Bali, Indonesia

2 Intern Medical Doctor, Department of Ophthalmology, Bali Mandara Eye Hospital, Denpasar, Bali, Indonesia

Address correspondence to:

Ni Made Indah Kencanawati

Denpasar, Bali 80233,

Indonesia

Access full text article on other devices

Access PDF of article on other devices

Article ID: 100020Z17NK2021

doi: 10.5348/100020Z17NK2021CR

How to cite this article

Kencanawati NMI, Santoso SA. How acute viral keratoconjunctivitis change the ocular tear film. J Case Rep Images Opthalmol 2021;4:100020Z17NK2021.

ABSTRACT

Introduction: Viral keratoconjunctivitis (VK) is one of the most common causes of red eye that affects many people and imposes economic and social burdens. It has a highly contagious nature which means that it can be spread easily from person to person. Acute VK can cause instability of tear film.

Case Report: A 32-year-old woman complained of bilateral eye redness for one week with a teary eye, sensitivity to light, and watery discharge but without blurred vision. Anterior segment examination revealed conjunctival hyperemia, edema, pseudomembrane, conjunctival vascular injection (CVI), and peripheral corneal vascular injection (PCVI) on both eyes with filament on the left eye. She had abnormal ST 1 (Schirmer’s Test 1), TBUT (Tear Break Up Time), with grade A-B Oxford Ocular Staining Score and high to low Ocular Surface Disease Index (OSDI) score up to 28 days follow-up, with positive immunoglobulin G Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) rapid test.

Conclusion: This patient had acute viral infection based on symptoms and clinical signs that make ocular tear film instability up to 28 days based on diagnostic tests.

Keywords: Dry eye, Tear film, Viral keratoconjunctivitis

Introduction


Conjunctivitis is one of the most common causes of red-eye that affects many people and imposes burdens. It is estimated that acute conjunctivitis affects 6 million people annually in the United States. Its prevalence varies according to the underlying cause. Viral conjunctivitis by adenovirus is the most common cause of infectious conjunctivitis. Adenoviral infection can affect the conjunctiva, corneal, and make changes to the tear film. Its highly contagious nature, long incubation period, and lack of gold standard testing or treatment cause adenoviral conjunctivitis to be a significant global economic burden [1],[2],[3][4],[5],[6].

Case Report


A 32-year-old woman complained of bilateral eye redness for one week with a teary eye, sensitivity to light, and watery discharge but without blurred vision. She did not feel like scratching her eye. She complained of a productive cough, stuffy nose, but without fever or pain in her eyes. She works at the bank using a computer, and she had a ractive lens exchange operation two years ago because of high myopia. There was no systemic condition such as immunocompromised or allergy. Her visual acuity was 6/6 on both eyes. Anterior segment examination revealed conjunctival hyperemia, edema, pseudomembrane, CVI, and PCVI on both eyes with filament on the left eye (Figure 1). She was given non-preservatives artificial tears eye drop and told to keep hygiene. She planned for several tests: ST 1, TBUT, Oxford Ocular Staining Score, and Ocular Surface Disease Index (OSDI) questionnaire. The following-up symptoms worsen on both eyes. She had membrane peeling with fluorometholone 0.1%, ofloxacin, non-preservative artificial tears eye drop. The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) rapid test came with positive IgG (Immunoglobulin G) result. After 14 days follow-up she had pseudomembrane with PCVI on both eyes (Figure 2). She had abnormal ST 1 and TBUT test evaluation on both eyes (Figure 3), with grade A-B Oxford Ocular Staining Score and high to low OSDI score up to 28 days follow-up (Figure 4). She achieved complete resolution after 28 days on both eyes (Figure 5).

Figure 1: Conjunctival hyperemia, edema, pseudomembrane, CVI, and PCVI on both eyes with filament on the left eye.
Figure 2: Pseudomembrane with PCVI on both eyes.
Figure 3: (A) Schirmer’s test 1 evaluation on both eyes. (B) TBUT test evaluation on both eyes.
Figure 4: (A) Oxford Ocular Staining Score. (B) OSDI score from high to low.
Figure 5: The patient achieved complete resolution after 28 days on both eyes.

Discussion


The conjunctiva covers two-thirds of the ocular surface from the corneal rim to the lid margin. The epithelium of conjunctiva has barrier function, mucin secretion, and immune defense [1],[2]. Characteristics of viral conjunctivitis include redness, blood vessel engorgement, ocular discharge, photophobia, and pseudomembranes [1],[2],[3]. The patients had characteristics like conjunctival hyperemia and edema because of proinflammatory cytokines like TNF-α (Tumor Necrosis Factor α) that induced conjunctival vasodilatation and capillary leakage, a follicular reaction which appears as avascular, round, or oval clusters of lymphocytes [4],[5],[6],[7],[8].

Those presenting with viral conjunctivitis usually have a recent history of upper respiratory tract infection or recent contact with a sick individual. Visual acuity is usually at or near their baseline vision. The cornea can have subepithelial infiltrates that can decrease the vision and cause light sensitivity [3],[6],[8]. This patient had a recent history of upper respiratory tract infection with normal visual acuity when she came to the hospital.

The incidence rate of pseudomembranous conjunctivitis is 3.47/10,000 people-year with approximately 20% of it caused by adenoviral conjunctivitis and had a mean duration of 7.86 days [6], same as this patient who occurred at seven days. Pseudomembrane should be removed by membrane peeling because it could potentially form a conjunctival scar and symblepharon, and given an antimicrobial cover of infective cause. Complications that can occurred: 16.7% subepithelial infiltrates, 20.81% corneal erosions, 3.5% filamentary keratitis, and 6.1% subtarsal fibrosis [7],[8].

Filamentary keratitis (FK) describes a condition in which filaments are adherent complexes of mucus and corneal epithelium that are present on the corneal surface. Three main factors that contribute to corneal filament formation are abnormal epithelium acting as mucus receptors, abnormal tear movement, and the abnormal shear relationship between the upper lid and globe [9],[10],[11]. Filamentary keratitis in this patient happened because she has keratoconjunctivitis and post-ractive lens surgery because of high myopia. These risk factors can make alternation of the tear film.

We had SARS-CoV-2 rapid test because it had shown common clinical aspects with another viral conjunctivitis, such as follicular reaction, and conjunctival hyperemia and discharge. A study found distinctive clinical findings defining conjunctivitis in COVID-19 (Coronavirus) patients. 54.29% of COVID-19 conjunctivitis were completely unilateral. The degree of conjunctival hyperemia was mild or very mild, no pseudomembrane or membrane formation, and self-limited within 2–4 days [12],[13].

Acute conjunctivitis cases can make several changes on the tear film. First, change of lipid or mucin composition which affects antimicrobial enzymes and anti-inflammatory mediators. Second, lower TBUT results because the mucin layer and the conjunctival goblet cells that secrete this layer have been affected [14],[15],[16],[17]. Third, had normal or lower Schirmer’s test result because lexive tear secretion is stimulated, and the aqueous component rate increased. Fourth, higher OSDI score where index demonstrates sensitivity and specificity in distinguishing between normal subjects and patients with a dry eye disease [18],[19],[20],[21]. In this patient, there were changes on it, which means that lower amounts of mucin and lipid composition bring about a decrease in tear stability [20],[21],[22],[23],[24].

Conjunctivitis treatment includes using artificial tears for lubrication four times a day or up to ten times a day with preservative-free tears because preservatives induce toxic epithelial damage and accentuate inflammation. Cool compresses with a wet washcloth to the periocular area may provide symptomatic relief [1],[2],[3],[6],[22]. Corticosteroids served as an anti-inflammatory component and alleviated patient symptoms but were advised to be reserved until patients present with pseudomembrane or symptomatic subepithelial infiltrates, because of potential side effects: promotion of viral replication and exacerbation of unrecognized herpes simplex infection [17],[20],[21]. The patient was given artificial tears with preservatives free combination with steroid and achieved a resolution in 28 days.

Conclusion


Conjunctivitis is one of the most common causes of red-eye that affects many people and imposes burdens. Adenoviral conjunctivitis is the most common cause of viral conjunctivitis infection. This patient had acute viral infection based on symptoms and clinical signs that make ocular tear film instability up to 28 days. We can conclude that the lack of clinical signs of viral replication is an important sign of disease improvement, but it does not imply complete resolution of the infection.

REFERENCES


1.

Azari AA, Barney NP. Conjunctivitis: A systematic review of diagnosis and treatment. JAMA 2013;310(16):1721–9. [CrossRef] [Pubmed] Back to citation no. 1  

2.

Azari AA, Arabi A. Conjunctivitis: A systematic review. J Ophthalmic Vis Res 2020;15(3):372–95. [CrossRef] [Pubmed] Back to citation no. 1  

3.

Chigbu DI, Labib BA. Pathogenesis and management of adenoviral keratoconjunctivitis. Infect Drug Resist 2018;11:981–93. [CrossRef] [Pubmed] Back to citation no. 1  

4.

Asena L, Özdemir E?, Burcu A, Ercan E, Çolak M, Alt?nörs DD. Comparison of clinical outcome with different treatment regimens in acute adenoviral keratoconjunctivitis. Eye (Lond) 2017;31(5):781–7. [Pubmed] Back to citation no. 1  

5.

Polat N, Tuncer ?. Tears stability of acute infective and allergic conjunctivitis. J Turgut Ozal Med Cent 2014;21(3):177–80. Back to citation no. 1  

6.

Hoffman J. Adenovirus: Ocular manifestations. Community Eye Health 2020;33(108):73–5. [Pubmed] Back to citation no. 1  

7.

Pepose JS, Narvekar A, Liu W, Haque R. A randomized controlled trial of povidone-iodine/dexamethasone ophthalmic suspension for acute viral conjunctivitis. Clin Ophthalmol 2019;13:535–44. [CrossRef] [Pubmed] Back to citation no. 1  

8.

Ho D, Lim S, Kim Teck Y. Pseudomembranous conjunctivitis: A possible conjunctival foreign body aetiology. Cureus 2020;12(5):1–7. [CrossRef] [Pubmed] Back to citation no. 1  

9.

Pentapati M, Shah S. Filamentary keratitis: A case series. Int J Sci Res Publ 2015;5(3). Back to citation no. 1  

10.

Chen S, Ruan Y, Jin X. Investigation of the clinical features in filamentary keratitis in Hangzhou, east of China. Medicine (Baltimore) 2016;95(35):e4623. [Pubmed] Back to citation no. 1  

11.

Sharma M, Sareen NS. Filamentary keratitis. Delhi J Ophthalmol 2018;28(4):67–8. [CrossRef] Back to citation no. 1  

12.

Ma X, Lu Y. Bilateral tear film alterations in patients with unilateral quiescent herpes simplex keratitis. Acta Ophthalmol 2017;95(6):629–33. [CrossRef] [Pubmed] Back to citation no. 1  

13.

Güemes-Villahoz N, Burgos-Blasco B, García-Feijoó J, et al. Conjunctivitis in COVID-19 patients: Frequency and clinical presentation. Graefe’s Arch Clin Exp Ophthalmol 2020;258(11):2501–7. [CrossRef] [Pubmed] Back to citation no. 1  

14.

Chen L, Liu M, Zhang Z, et al. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Br J Ophthalmol 2020;104(6):748–51. [CrossRef] [Pubmed] Back to citation no. 1  

15.

Nebbioso M, Del Regno P, Gharbiya M, Sacchetti M, Plateroti R, Lambiase A. Analysis of the pathogenic factors and management of dry eye in ocular surface disorders. Int J Mol Sci 2017;18(8):1764. [CrossRef] [Pubmed] Back to citation no. 1  

16.

Rossi GCM. Diagnosis and treatment methods for ocular surface disease in glaucoma. Eur Ophthalmic Rev 2014;8(1):40–3. [CrossRef] Back to citation no. 1  

17.

Yamaguchi T. Inflammatory response in dry eye. Invest Ophthalmol Vis Sci 2018;59(14):DES192–9. [CrossRef] [Pubmed] Back to citation no. 1  

18.

Zhang X, M VJ, Qu Y, et al. Dry eye management: Targeting the ocular surface microenvironment. Int J Mol Sci 2017;18(7):1398. [CrossRef] [Pubmed] Back to citation no. 1  

19.

Craig JP, Nelson JD, Azar DT, et al. TFOS DEWS II report executive summary. Ocul Surf 2017;15(4):802– 12. [CrossRef] [Pubmed] Back to citation no. 1  

20.

Begley C, Caffery B, Chalmers R, Situ P, Simpson T, Nelson JD. Review and analysis of grading scales for ocular surface staining. Ocul Surf 2019;17(2):208–20. [CrossRef] [Pubmed] Back to citation no. 1  

21.

Ko BY, Xiao Y, Barbosa FL, de Paiva CS, Pflugfelder SC. Goblet cell loss abrogates ocular surface immune tolerance. JCI Insight 2018;3(3):e98222. [CrossRef] [Pubmed] Back to citation no. 1  

22.

Bron AJ, de Paiva CS, Chauhan SK, et al. TFOS DEWS II pathophysiology report. Ocul Surf 2017;15(3):438–510. [CrossRef] [Pubmed] Back to citation no. 1  

23.

Ning Y, Bhattacharya D, Jones RE, et al. Evaluating the functionality of conjunctiva using a rabbit dry eye model. J Ophthalmol 2016;2016:3964642. [CrossRef] [Pubmed] Back to citation no. 1  

24.

Palomar APD, Montolío A, Cegoñino J, et al. The innate immune cell profile of the cornea predicts the onset of ocular surface inflammatory disorders. J Clin Med 2019;8(12):2110. [CrossRef] [Pubmed] Back to citation no. 1  

SUPPORTING INFORMATION


Author Contributions

Ni Made Indah Kencanawati - Substantial contributions to conception and design, Acquisition of data, Analysis of data, Interpretation of data, Drafting the article, Final approval of the version to be published

Stephanie Aurelia Santoso - Acquisition of data, Analysis of data, Interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published

Data Availability Statement

The corresponding author is the guarantor of submission.

Consent For Publication

Written informed consent was obtained from the patient for publication of this article.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Competing Interests

Authors declare no conflict of interest.

Copyright

© 2021 Ni Made Indah Kencanawati et al. This article is distributed under the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any medium provided the original author(s) and original publisher are properly credited. Please see the copyright policy on the journal website for more information.